Novartis Ag (NVS) Change in Taxes (2009 - 2017)
Novartis Ag (NVS) posted Change in Taxes of $353.0 million for Q3 2017, up 5.06% sequentially from $336.0 million in Q2 2017, and up 7.29% YoY from $329.0 million in Q3 2016.
Novartis Ag (NVS) Change in Taxes (2009 - 2017) Analysis & Trends
Novartis Ag (NVS) has 7 years of Change in Taxes data on file, last reported at $353.0 million in Q3 2017.
- Quarterly Change in Taxes rose 7.29% year-over-year to $353.0 million in Q3 2017, while the trailing twelve-month figure through Sep 2017 was $1.1 billion (up 5.6% YoY) and the FY2016 annual result came in at $648.0 million, changed N/A from the prior year.
- Change in Taxes grew to $353.0 million in Q3 2017 per NVS's latest filing, from $336.0 million in the prior quarter.
- The five-year high for Change in Taxes was $357.0 million in Q3 2015, with the low at $268.0 in Q4 2013.
- Average Change in Taxes over 5 years is $132.8 million, with a median of $447.0 recorded in 2013.
- Year-over-year, Change in Taxes fell 29.25% in 2015 and jumped 102333233.33% in 2016.
- Novartis Ag's Change in Taxes stood at $268.0 in 2013, then advanced by 14.93% to $308.0 in 2014, then surged by 24999900.0% to $77.0 million in 2015, then soared by 84.42% to $142.0 million in 2016, then jumped by 148.59% to $353.0 million in 2017.
- Business Quant data shows NVS's Change in Taxes at $353.0 million in Q3 2017, $336.0 million in Q2 2017, and $282.0 million in Q1 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | - |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -81.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -526.00 Mn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 71.00 Mn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | -29.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | 18.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 353.00 Mn |
| Sep 30, 2017 | 353.00 Mn |
| Jun 30, 2017 | 336.00 Mn |
| Jun 30, 2017 | 336.00 Mn |
| Mar 31, 2017 | 282.00 Mn |
| Mar 31, 2017 | 282.00 Mn |
| Dec 31, 2016 | 142.00 Mn |
| Dec 31, 2016 | 142.00 Mn |
| Sep 30, 2016 | 329.00 Mn |
| Sep 30, 2016 | 329.00 Mn |
| Jun 30, 2016 | 307.00 Mn |
| Jun 30, 2016 | 307.00 Mn |
| Mar 31, 2016 | 341.00 Mn |
| Mar 31, 2016 | 341.00 Mn |
| Dec 31, 2015 | 77.00 Mn |
| Dec 31, 2015 | 77.00 Mn |
| Sep 30, 2015 | 357.00 Mn |
| Sep 30, 2015 | 357.00 Mn |
| Jun 30, 2015 | 300.00 |
| Jun 30, 2015 | 300.00 |